Net sales were 15,045 million yen, a 0.2% decrease year-over-year. Operating loss was 131 million yen, ordinary loss was 106 million yen, and quarterly net loss attributable to owners of the parent was 101 million yen. Full-year forecasts remain unchanged from the prior announcement. Increased spending on logistics expansion investments and rising personnel costs impacted results. By segment, medical device sales recorded net sales of 15,068 million yen and segment profit decreased to 212 million yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9265","jir_company_name":"Yamashita Health Care Holdings,Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-30","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/9265-20260930-01.pdf","jir_short_summary":"Net sales were 15,045 million yen, a 0.2% decrease year-over-year. Operating loss was 131 million yen, ordinary loss was 106 million yen, and quarterly net loss attributable to owners of the parent was 101 million yen. Full-year forecasts remain unchanged from the prior announcement. Increased spending on logistics expansion investments and rising personnel costs impacted results. By segment, medical device sales recorded net sales of 15,068 million yen and segment profit decreased to 212 million yen.","jir_summary":"### Overview of Performance\nIn this quarter's consolidated results, net sales were almost flat year-over-year, but profit was pressured by increased expenses related to automation investments in logistics and higher personnel costs. In the segment centered on medical device sales, despite an increase in examinations and surgical procedures, a decline in demand for capital equipment led to a reduction in gross profit margin and higher selling, general and administrative expenses, resulting in an operating loss. Automation investments at the logistics center of a core subsidiary and the introduction of material handling equipment are progressing to achieve long-term operational efficiency. The full-year forecast remains at the previously announced level.\n\n### Outlook and Impact\nAs this is the final year of the mid-term management plan, we will promote strengthening our management base and improving the human resources foundation. In the short term, it is expected to take time to stabilize sales and improve profitability; however, through operational efficiencies from logistics automation and strict cost management, we aim to improve long-term profitability. By segment, despite a challenging environment for medical device sales, we will continue to expand sales in minimally invasive and specialty fields.","jir_financial_highlights":"Net Sales: 15,045 million yen (Year-over-Year -0.2%)\nOperating Income: -131 million yen (Year-over-Year N\/A)\nOrdinary Income: -106 million yen (Year-over-Year N\/A)\nQuarterly Net Income Attributable to Owners of Parent: -101 million yen (Year-over-Year N\/A)\nEquity Ratio: 35.6% (Approx. +1.0pt from prior period)","jir_category":"","jir_hashtags":"#YamashitaHealthCareHoldingsInc., #Earnings, #MedicalDeviceSales","jir_key_figures":"Net Sales: 15,045 million yen (Year-over-Year -0.2%)\nOperating Loss: 131 million yen\nQuarterly Net Loss Attributable to Owners of Parent: 101 million yen","jir_meta_title":"Yamashita Health Care Holdings,Inc. Fiscal 2027 Q1 Financial Summary | Net Sales Slightly Down, Operating Loss Expanded","jir_meta_description":"Summary of Yamashita Health Care Holdings,Inc.'s fiscal 2027 first quarter results: net sales, operating loss, ordinary loss, net loss, segment trends, and future policy highlights.","jir_og_title":"Yamashita Health Care HD | Fiscal 2027 Q1 Financial Results","jir_og_description":"Net sales were flat while operating loss widened. Automation investments at a core subsidiary's logistics center are underway. We will strengthen initiatives to improve profitability and support long-term growth.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2026-06\\\",\\\"2026-07\\\",\\\"2026-08\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[15045,15078,15045]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2026-06\\\",\\\"2026-07\\\",\\\"2026-08\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[36, -131, -131]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Net Sales Breakdown\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"General Equipment\\\",\\\"General Consumables\\\",\\\"Minimally Invasive Treatment\\\",\\\"Specialty\\\",\\\"Information & Services\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[1250,6815,3540,3182,279]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Operating Profit\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Medical Device Sales\\\",\\\"Medical Device Manufacturing & Sales\\\",\\\"Medical Mall Business\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Segment Profit\\\",\\\"data\\\":[357,-63,1]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"table\", \"jir_chart_title\": \"Full-Year Forecast vs. Quarterly Results\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"table\\\",\\\"data\\\":{}}\"}]","ir_related_company":122822,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-125367","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n